{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:14:54Z","timestamp":1783606494441,"version":"3.55.0"},"reference-count":54,"publisher":"Portland Press Ltd.","issue":"7","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Novartis Stiftung f\u00fcr Medizinisch-Biologische Forschung","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Dr. Rolf M. Schwiete Stiftung","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>As the spread of antimicrobial resistance outpaces antibiotic discovery and marketing, there is a critical need to revisit approved compounds with untapped potential. Metal-based complexes (metallo-antimicrobials) represent ideal candidates for such efforts due to their pleiotropic effects, which, unlike antibiotics with single protein targets, may have lower resistance potential. With its well-characterised safety profile, nitroxoline, an 8-hydroxyquinoline derivative, is a prominent compound of this kind. Here, we review recent advances in our understanding of nitroxoline\u2019s multimodal mode of action, focusing on its disruption of metal homeostasis at the intracellular and extracellular level. We further explore its clinical utility, including its low propensity for resistance development, and its potential for both combinatorial therapy and as an anti-biofilm agent. Although beyond the scope of the present review, we refer to nitroxoline\u2019s antifungal effects whenever they represent a relevant comparison with its antibacterial activity. We highlight current knowledge gaps in nitroxoline\u2019s mechanism and in vivo activity that should be bridged to accelerate its repurposing, particularly in the treatment of multidrug-resistant and biofilm-associated infections. Several recent reviews have examined nitroxoline from chemical, clinical, and repurposing perspectives [1, 2, 3, 4]. The present work complements these by providing a mechanistic synthesis of nitroxoline\u2019s effects in bacteria, linking its multimodal mode of action to the knowledge gaps that should be addressed before clinical repurposing can proceed.<\/jats:p>","DOI":"10.1042\/bst20250045","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:24:51Z","timestamp":1783603491000},"page":"937-947","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nitroxoline revisited: antibacterial mechanisms, spectrum, and therapeutic potential of an old drug in the era of antimicrobial resistance"],"prefix":"10.1042","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8239-0353","authenticated-orcid":false,"given":"Elisabetta","family":"Cacace","sequence":"first","affiliation":[{"name":"1Department of Biology, Institute of Microbiology and Swiss Institute of Bioinformatics, ETH Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6896-5309","authenticated-orcid":false,"given":"Stephan","family":"G\u00f6ttig","sequence":"additional","affiliation":[{"name":"2Institute for Medical Microbiology and Infection Control, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany"},{"name":"3University Center for Infectious Diseases (UCI), University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"2026070909244831200_B1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.5562\/cca4187","article-title":"Small molecule, big potential\u2014nitroxoline in the era of rising antimicrobial resistance","volume":"98","author":"Petkovi\u0107 Didovi\u0107","year":"2025","journal-title":"Croat. Chem. Acta."},{"key":"2026070909244831200_B2","doi-asserted-by":"publisher","first-page":"104419","DOI":"10.1016\/j.drudis.2025.104419","article-title":"Rediscovering nitroxoline: a metal-chelating agent bridging infection and cancer","volume":"30","author":"Papareddy","year":"2025","journal-title":"Drug Discov. Today"},{"key":"2026070909244831200_B3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.5173\/ceju.2024.17","article-title":"Nitroxoline: treatment and prevention of urinary tract infections from the urologist\u2019s perspective","volume":"77","author":"Krajewski","year":"2024","journal-title":"Cent. European J. Urol."},{"key":"2026070909244831200_B4","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3390\/antibiotics11081105","article-title":"Chelation in antibacterial drugs: from nitroxoline to cefiderocol and beyond","volume":"11","author":"Repac Anti\u0107","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"2026070909244831200_B5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1749-6632.1977.tb21985.x","article-title":"Inactivation and inhibition of Rous sarcoma virus by copper-binding ligands: thiosemicarbazones, 8-hydroxyquinolines, and isonicotinic acid hydrazide","volume":"284","author":"Levinson","year":"1977","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2026070909244831200_B6","first-page":"208","article-title":"Chelating drugs and zinc","volume":"33","author":"Weismann","year":"1986","journal-title":"Dan. Med. Bull."},{"key":"2026070909244831200_B7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbrep.2016.03.014","article-title":"Derivatives (halogen, nitro and amino) of 8-hydroxyquinoline with highly potent antimicrobial and antioxidant activities","volume":"6","author":"Cherdtrakulkiat","year":"2016","journal-title":"Biochem. Biophys. Rep."},{"key":"2026070909244831200_B8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1128\/AAC.39.3.707","article-title":"Roles of divalent cations and pH in mechanism of action of nitroxoline against Escherichia coli strains","volume":"39","author":"Pelletier","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026070909244831200_B9","first-page":"406","article-title":"Microbiological consequences of chelation of bivalent metal cations by nitroxoline","volume":"42","author":"Pelletier","year":"1994","journal-title":"Pathol. Biol. (Paris)"},{"key":"2026070909244831200_B10","first-page":"600","article-title":"Relation of the chelating property of nitroxoline, the surface hydrophobicity and the inhibition of bacterial adherence","volume":"37","author":"Bourlioux","year":"1989","journal-title":"Pathol. Biol. (Paris)"},{"key":"2026070909244831200_B11","first-page":"451","article-title":"Inhibition of bacterial adherence by nitroxoline on cellular adhesion and on urinary catheter surfaces","volume":"37","author":"Bourlioux","year":"1989","journal-title":"Pathol. Biol. (Paris)"},{"key":"2026070909244831200_B12","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1038\/s41467-025-58730-5","article-title":"Uncovering nitroxoline activity spectrum, mode of action and resistance across Gram-negative bacteria","volume":"16","author":"Cacace","year":"2025","journal-title":"Nat. Commun."},{"key":"2026070909244831200_B13","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00284-025-04575-6","article-title":"Nitroxoline shows synergy with colistin potentiating its bactericidal efficacy in opportunist pathogen Pseudomonas aeruginosa","volume":"82","author":"RoyChowdhury","year":"2025","journal-title":"Curr. Microbiol."},{"key":"2026070909244831200_B14","doi-asserted-by":"publisher","first-page":"2294854","DOI":"10.1080\/22221751.2023.2294854","article-title":"Novel nitroxoline derivative combating resistant bacterial infections through outer membrane disruption and competitive NDM-1 inhibition","volume":"13","author":"He","year":"2024","journal-title":"Emerg. Microbes Infect."},{"key":"2026070909244831200_B15","doi-asserted-by":"publisher","first-page":"107419","DOI":"10.1016\/j.bpc.2025.107419","article-title":"Copper(II) enhances the antibacterial activity of nitroxoline against MRSA by promoting aerobic glycolysis","volume":"320-321","author":"Huang","year":"2025","journal-title":"Biophys. Chem."},{"key":"2026070909244831200_B16","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1021\/acsinfecdis.4c00582","article-title":"8-hydroxyquinoline series exerts bactericidal activity against Mycobacterium tuberculosis via copper-mediated toxicity","volume":"10","author":"Bhagwat","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"2026070909244831200_B17","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.1128\/AAC.00325-16","article-title":"8-hydroxyquinolines are boosting agents of copper-related toxicity in Mycobacterium tuberculosis","volume":"60","author":"Shah","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026070909244831200_B18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neuron.2008.06.018","article-title":"Rapid restoration of cognition in Alzheimer\u2019s transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta","volume":"59","author":"Adlard","year":"2008","journal-title":"Neuron"},{"key":"2026070909244831200_B19","doi-asserted-by":"publisher","first-page":"e0183125","DOI":"10.1128\/aac.01831-25","article-title":"Nitroxoline exerts potent anti-Aspergillus fumigatus activity by disrupting copper homeostasis and inducing oxidative stress","volume":"70","author":"Zhang","year":"2026","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026070909244831200_B20","doi-asserted-by":"publisher","first-page":"8344","DOI":"10.1073\/pnas.0812808106","article-title":"The iron-sulfur clusters of dehydratases are primary intracellular targets of copper toxicity","volume":"106","author":"Macomber","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026070909244831200_B21","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1128\/JB.00058-10","article-title":"Copper stress affects iron homeostasis by destabilizing iron-sulfur cluster formation in Bacillus subtilis","volume":"192","author":"Chillappagari","year":"2010","journal-title":"J. Bacteriol."},{"key":"2026070909244831200_B22","doi-asserted-by":"publisher","first-page":"e01967","DOI":"10.1128\/AEM.01967-18","article-title":"Zinc toxicity and iron-sulfur cluster biogenesis in Escherichia coli","volume":"85","author":"Li","year":"2019","journal-title":"Appl. Environ. Microbiol."},{"key":"2026070909244831200_B23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1042\/bj1470401","article-title":"The mechanism of inhibition of ribonucleic acid synthesis by 8-hydroxyquinoline and the antibiotic lomofungin","volume":"147","author":"Fraser","year":"1975","journal-title":"Biochem. J."},{"key":"2026070909244831200_B24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1432-1033.1974.tb03597.x","article-title":"Rapid and selective inhibition of RNA synthesis in yeast by 8-hydroxyquinoline","volume":"46","author":"Fraser","year":"1974","journal-title":"Eur. J. Biochem."},{"key":"2026070909244831200_B25","doi-asserted-by":"publisher","first-page":"e02051","DOI":"10.1128\/mBio.02051-18","article-title":"Functional assessment of 2,177 U.S. and international drugs identifies the quinoline nitroxoline as a potent amoebicidal agent against the pathogen Balamuthia mandrillaris","volume":"9","author":"Laurie","year":"2018","journal-title":"MBio"},{"key":"2026070909244831200_B26","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.3390\/antibiotics12081280","article-title":"Repurposing of Nitroxoline as an alternative primary amoebic meningoencephalitis treatment","volume":"12","author":"Chao-Pellicer","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"2026070909244831200_B27","doi-asserted-by":"publisher","first-page":"100578","DOI":"10.1016\/j.ijpddr.2025.100578","article-title":"Nitroxoline evidence amoebicidal activity against Acanthamoeba castellanii through DNA damage and the stress response pathways","volume":"27","author":"Chen","year":"2025","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"2026070909244831200_B28","doi-asserted-by":"publisher","first-page":"445","DOI":"10.17179\/excli2019-1378","article-title":"Nitroxoline: a potent antimicrobial agent against multidrug resistant Enterobacteriaceae","volume":"18","author":"Cherdtrakulkiat","year":"2019","journal-title":"EXCLI J."},{"key":"2026070909244831200_B29","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1093\/jac\/dkac123","article-title":"In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract","volume":"77","author":"Fuchs","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"2026070909244831200_B30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ijantimicag.2016.10.017","article-title":"Nitroxoline: a broad-spectrum biofilm-eradicating agent against pathogenic bacteria","volume":"49","author":"Abouelhassan","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"2026070909244831200_B31"},{"key":"2026070909244831200_B32","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1128\/AAC.02147-13","article-title":"Urinary concentrations and antibacterial activities of nitroxoline at 250 milligrams versus trimethoprim at 200 milligrams against uropathogens in healthy volunteers","volume":"58","author":"Wagenlehner","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026070909244831200_B33","doi-asserted-by":"publisher","first-page":"107199","DOI":"10.1016\/j.mimet.2025.107199","article-title":"Biphasic bactericidal activity of nitroxoline against Acinetobacter baumannii assessed by Raman-DIP","volume":"236","author":"Yi","year":"2025","journal-title":"J. Microbiol. Methods"},{"key":"2026070909244831200_B34","doi-asserted-by":"publisher","first-page":"906097","DOI":"10.3389\/fphar.2022.906097","article-title":"In vitro activity of repurposed nitroxoline against clinically isolated mycobacteria including multidrug-resistant Mycobacterium tuberculosis","volume":"13","author":"Hoffmann","year":"2022","journal-title":"Front. Pharmacol."},{"key":"2026070909244831200_B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jgar.2023.02.010","article-title":"Activity of the old antimicrobial nitroxoline against Mycobacterium abscessus complex isolates","volume":"33","author":"Hoffmann","year":"2023","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"2026070909244831200_B36","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0924-8579(01)00437-X","article-title":"In vitro activity of the chelating agents nitroxoline and oxine against Mycobacterium bovis BCG","volume":"18","author":"Murugasu-Oei","year":"2001","journal-title":"Int. J. Antimicrob. Agents"},{"key":"2026070909244831200_B37","first-page":"669","article-title":"Clinical study and effect of nitroxoline on fecal flora in children","volume":"35","author":"Lambert-Zechovsky","year":"1987","journal-title":"Pathol. Biol."},{"key":"2026070909244831200_B38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/antibiotics15010062","article-title":"In vitro and in vivo evaluation of nitroxoline as an effective antimicrobial alternative to poultry production","volume":"15","author":"Zhou","year":"2026","journal-title":"Antibiotics (Basel)"},{"key":"2026070909244831200_B39","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1128\/AAC.01484-12","article-title":"The urinary antibiotic 5-nitro-8-hydroxyquinoline (Nitroxoline) reduces the formation and induces the dispersal of Pseudomonas aeruginosa biofilms by chelation of iron and zinc","volume":"56","author":"Sobke","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026070909244831200_B40","doi-asserted-by":"publisher","first-page":"101595","DOI":"10.1016\/j.mycmed.2025.101595","article-title":"Nitroxoline and its combination with antifungals: an alternative for the treatment of fungal biofilm","volume":"36","author":"de Souza","year":"2026","journal-title":"J. Mycol. Med."},{"key":"2026070909244831200_B41","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/jac\/dkz434","article-title":"Mutations that increase expression of the EmrAB-TolC efflux pump confer increased resistance to nitroxoline in Escherichia coli","volume":"75","author":"Pu\u00e9rtolas-Balint","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"2026070909244831200_B42","doi-asserted-by":"publisher","first-page":"e0307923","DOI":"10.1128\/spectrum.03079-23","article-title":"Nitroxoline resistance is associated with significant fitness loss and diminishes in vivo virulence of Escherichia coli","volume":"12","author":"Deschner","year":"2023","journal-title":"Microbiol Spectr"},{"key":"2026070909244831200_B43","doi-asserted-by":"publisher","first-page":"114003","DOI":"10.1016\/j.isci.2025.114003","article-title":"Nitroxoline as an antimicrobial synergist reverses colistin resistance in multidrug-resistant Escherichia coli","volume":"28","author":"Wang","year":"2025","journal-title":"iScience"},{"key":"2026070909244831200_B44","doi-asserted-by":"publisher","first-page":"e0106322","DOI":"10.1128\/spectrum.01063-22","article-title":"In vitro selective combinatory effect of ciprofloxacin with nitroxoline, sanguinarine, and zinc pyrithione against diarrhea-causing and gut beneficial bacteria","volume":"10","author":"Osei-Owusu","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"2026070909244831200_B45","doi-asserted-by":"publisher","first-page":"6038","DOI":"10.3390\/ijms25116038","article-title":"Evaluation of in vitro synergistic effects of tetracycline with alkaloid-related compounds against diarrhoeic bacteria","volume":"25","author":"Osei-Owusu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"2026070909244831200_B46","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/antibiotics13090829","article-title":"Combinatory effect of nitroxoline and gentamicin in the control of uropathogenic enterococci infections","volume":"13","author":"Repac Anti\u0107","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"2026070909244831200_B47","doi-asserted-by":"publisher","first-page":"113975","DOI":"10.1016\/j.ejmech.2021.113975","article-title":"Nitroxoline and its derivatives are potent inhibitors of metallo-\u03b2-lactamases","volume":"228","author":"Proschak","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"2026070909244831200_B48","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1186\/s12879-014-0628-7","article-title":"Review of the literature and individual patients\u2019 data meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infections","volume":"14","author":"Naber","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"2026070909244831200_B49","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1093\/jac\/dky255","article-title":"Review of the pharmacokinetic properties of nitrofurantoin and nitroxoline","volume":"73","author":"Wijma","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"2026070909244831200_B50","first-page":"482","article-title":"Appropriate nitroxoline dosage regimen design","volume":"17","author":"Karba","year":"1979","journal-title":"Int. J. Clin. Pharmacol. Biopharm."},{"key":"2026070909244831200_B51","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s00120-017-0389-1","article-title":"Epidemiologie, Diagnostik, Therapie, Pr\u00e4vention und Management unkomplizierter, bakterieller, ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten: Aktualisierung 2017 der interdisziplin\u00e4ren AWMF S3-Leitlinie","volume":"56","author":"Kranz","year":"2017","journal-title":"Urologe A"},{"key":"2026070909244831200_B52","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1007\/s00120-023-02167-5","article-title":"Therapy of cystitis with nitroxoline-NitroxWin: prospective, multicenter, non-interventional study and microbiological resistance surveillance","volume":"62","author":"Wagenlehner","year":"2023","journal-title":"Urologie"},{"key":"2026070909244831200_B53","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.cmi.2017.11.007","article-title":"Nitroxoline in geriatric patients with lower urinary tract infection fails to achieve microbiological eradication despite clinical improvement: a non-comparative, prospective observational study","volume":"24","author":"Forstner","year":"2018","journal-title":"Clin Microbiol Infect."},{"key":"2026070909244831200_B54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00120-025-02641-2","article-title":"Prophylaxis of recurrent urinary tract infections by nitroxoline-real-world data of the ProNitrox study","volume":"65","author":"Wiedemann","year":"2026","journal-title":"Urologie"}],"container-title":["Biochemical Society Transactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/54\/7\/937\/990095\/bst-2025-0045c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/54\/7\/937\/990095\/bst-2025-0045c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:24:53Z","timestamp":1783603493000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article\/54\/7\/937\/237814\/Nitroxoline-revisited-antibacterial-mechanisms"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":54,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,9]]},"published-print":{"date-parts":[[2026,7,29]]}},"URL":"https:\/\/doi.org\/10.1042\/bst20250045","relation":{},"ISSN":["0300-5127","1470-8752"],"issn-type":[{"value":"0300-5127","type":"print"},{"value":"1470-8752","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,7]]}}}